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Myomectomy by robotically assisted
laparoscopic surgery: results at Foch
Hospital, Paris
Jennifer Asmar, Marc Even, Marie Carbonnel*, Julie Goetgheluck, Aurelie Revaux and
Jean Marc Ayoubi
Foch Hospital, Suresnes, France
We reported an observational, retrospective chart review of 36 women who underwent
robotic myomectomy at the Department of Obstetrics and Gynecology, Foch Hospital.
Short- and long-term results were analyzed. We compared our results with literature data.
Potential advantages and limits of robotic surgery in myomectomy are discussed.
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Introduction
Uterine myomas are common benign tumors encountered in 30% of women of reproductive age
and even more beyond 49 years of age (1). The common symptoms reported by women who have
fibroids are menorrhagia, pelvic pressure or pain, and urinary symptoms. Also, fibroids that occupy
the uterine cavity are responsible of infertility (2), and complications during pregnancy, such as
miscarriages. Earlier diagnoses and a tendency for delaying childbearing have increased the need
for uterine-sparing techniques in the surgical treatment of fibroids. The only surgical treatment that
allows future pregnancies is the myomectomy, which can be done by laparotomy, laparoscopy, and
recently robotic surgery.
Traditionally, myomectomy was performed by laparotomy. Recovery following surgery took
4–6weeks. Laparoscopic surgery is usually performed as out-patient surgery under general anesthe-
sia and has revolutionized gynecologic surgery. Studies have suggested that laparoscopic myomec-
tomy leads to lowermorbidity rates, better anesthetic results, less adhesions, and faster recovery than
does laparotomic myomectomy (3, 4). Yet, laparoscopy has also its limits, as the quality of sutures
still remains uncertain (5) and it is sometimes impossible to operate on large, poorly accessible, and
multiple fibroids (6, 7). The technical difficulties encountered with laparoscopies are responsible of
long learning curves (6). Although hard to evaluate, the rate of uterine rupture appears to be around
1% for both techniques (8, 9).
Robotically assisted laparoscopy constitutes a solution capable of overcoming certain limits of
standard laparoscopy, as it enables easier suturing and can overcome laparoscopy’s limits (acces-
sibility, size, number of fibroids). Its learning curve is significantly shorter, especially for complex
procedures (10), but the data available are limited. This paper therefore aims at sharing our own
experience using robotic surgery for myomectomy.
Materials and Methods
Surgical Procedure
The Da Vinci SI High Definition four arm robotic system was used to perform all the surgeries of
the study. After induction of general anesthesia, the patient was put in a dorsal lithotomy position.
A uterine positioning systemwas used tomobilize the uteruswith an intrauterine canula. Then, three
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to four standard, 0.7 cm incisions (depending on the technical
difficulty of the surgery)weremade andportswere inserted for the
robot’s camera and instrument arms. The robot was then docked:
the tower, which contains the robot’s four arms (three that can
hold surgical instruments: monopolar scissors, bipolar surgical
clamp, needle holders and a fourth that holds the system’s 3-D
cameras) was positioned directly over the patient during surgery.
These arms are controlled by a computer that exactly replicates the
movements exerted by the operating surgeon on the joystick. The
surgeon sitting behind the console operated the robot’s controls
while looking into a stereoscopic monitor that provides a high
definition 3-D view of the surgical site. The robot’s four arms were
manipulated by maneuvering two master joysticks for a fingertip
control precision of movement. The surgeon had also access to
foot pedals providing additional options, such as the ability to
switch between two different energy sources. Robotically assisted
laparoscopic myomectomy was performed using the monopolar
scissors and the bipolar grasping device, while sometimes using
the fourth arm of the robot for myoma traction. After the incision
in the uterus, the fibroid was excised and extracted from the
surrounding uterine tissue. Finally, the uterus was sutured before
removing the robot. The myomectomy site was sutured in one
myometrial planes, usually by x-shape Vicryl 1® stitches, and the
uterine serosa was sutured by 4.0 monofilament overedge stitches
in order to reduce the risk of adhesion. Then, a morcellator was
placed and used to cut the fibroid into smaller pieces inside the
patient’s abdomen after withdrawing the robot arms for more
safety. Finally, these pieces were removed through one of the ports.
An anti-adhesion gel was applied at the end of procedure in some
cases.
Study and Patients Description
The study was conducted as an observational, retrospective chart
review. All the women diagnosed with uterine myomas who
underwent robotic surgery from 1/2011 to 10/2014 were eligi-
ble for inclusion. Polymyomectomy for three myomas or more,
myoma size exceeding 12 cm or suspicion of malignity were
generally excluded because laparotomy was performed in these
cases. But, we realized by robotic surgery cases to establishing
the limits of robotic surgery. This explains that some cases had
more than three myomas and size ranged up to 15 cm. In theses
cases, patients were informed of a significant risk of laparoconver-
sion. Oral and written informed consent about myomectomy and
robotic surgery was given for each patients. Risks and controver-
sies about morcellation were explained. Information concerning
age, BMI, number of fibroids, localization, details of surgery,
and direct complications was collected by screening patients’ files
(surgery, anesthesia, and hospitalization reports). Information
concerning long-term complications and consequences of surgery
was collected by follow-up phone calls, at least 6months after
surgery. During the study period, 36 women underwent robotic
myomectomy at the Department of Obstetrics and Gynecology,
Foch Hospital.
Mean age was 39.1 years (21; 55). Six women were operated
for treating infertility with fibroids distorting the uterine cavity,
24 because of pelvic pains associated with dysfunctional uterine
bleeding (DUB), 5 for urinary disorders, and 1 because of pelvic
distension. Average gestity was 1.13 (0; 8), average parity was 0.84
(0; 6). Ten of our patients had prior abdominal or pelvic surgery,
including six laparotomies.
Results
The average duration of the procedure was 161min (65; 308).
It was conducted under general anesthesia, as for laparoscopies,
lasting 203min (115; 375) on average. In 26 cases, 1 fibroid was
removed, in 4 cases 2, in 3 cases 3, in 2 cases 4, and in 1 case 5
fibroids were removed. The mean weight and diameter of fibroids
were 163.37 g (10; 400) and 73mm (10; 150), respectively. Inmore
than 70% of the cases (26/36), the uterus was sutured in two plans.
Average blood loss during the surgery was 384ml (50; 1000). No
patients needed blood transfusion. For adhesion prevention, nine
patients received Hyaloronic acid gel (Hyalobarrier®) and two of
Icodextrine 4% solution (Adept®). Three cases of laparoconver-
sion took place. One was necessary because of important bleeding
during surgery after removing a 8 cm isthmic anterior myoma. In
this case, laparotomic exploration showed that the hysterotomy
was not completely sutured, and that the blood loss came from
under the right broad ligament. Therefore, the surgeon achieved
a ligature and section of the right round ligament and then the
ligature and section of the right uterine artery after spotting the
right ureter in order to achieve adequate hemostasis. The two
others were because of the excessive size of the fibroids, exceeding
8 cm diameter (15 and 13 cm), and compelling the surgeon to
use the laparotomic procedure to remove the myomas, because of
the extreme technical difficulty of doing it by minimally invasive
surgery with an increase blood loss. In one patient, a visceral
wound (vesical) occurred during surgery, 1 cm long, sutured by
three stitches.
Short-Term Results
One immediate complication was reported at day 1 after surgery:
a hemorrhagic duodenal ulcer that has required transfusion. The
median hospitalization duration was of 3.29 days (1–12). Seven
cases of anemia (with a hemoglobin rate of 10, 10.7, 8.6, 7, 8.8,
9.7, and 8.5) caused by excessive blood loss during surgery, were
reported during hospitalization, none had required transfusion.
One woman suffered of an abdominal scar sore, 15 days after her
surgery, treated by only local treatment.
Long-Term Results
After surgery, women were advised not to try to get pregnant
before a delay of 6months. Therefore, pregnancy data were only
analyzed for women with a 6-month follow-up or more. Con-
cerning women operated before April 2014 (32 women) and
for which we had at least 6months of follow-up, 5 patients
desired a pregnancy, 4 obtained it. One got pregnant after
10months, thanks to an ICSI procedure that had failed before
the surgery. Another got pregnant after 6months thanks to a
FIV procedure (when six IIU had failed before the surgery),
and two women got pregnant spontaneously, <6months after
the surgery. Unfortunately, one of these pregnancies ended up
in a miscarriage, the second woman gave birth in October
2014.
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No woman suffered from infection associated to the surgery,
resistant pain, or had needed a rehospitalization for any reason.
Only one woman had complaints about the esthetics of her scars.
Discussion
Laparotomy is the traditional procedure used for myomectomy. It
was first considered as a medical revolution as it enabled surgeons
to remove fibroids avoiding hysterectomy and allowing women to
consider future pregnancies. However, laparotomy was respon-
sible of aftermath, such as adhesions (6) and heavy post surgery
symptoms (blood loss, pain, long hospitalization duration.) (7).
Laparoscopy has clearly shown its short-termbenefits in several
studies, compared to laparotomy, such as reduced post operative
pain, shorter hospital stay, and faster recovery. It also proved
its similar therapeutic efficacy and safety (for myomas of 6 cm
diameter and if their number did not exceed four myomas).
Concerning long-term benefits, laparoscopy decreases adhesion
rates (9).
However, technically, laparoscopy is a more difficult procedure
for surgeons, especially when fibroids are not easily accessible or
when>8 cm in size. Sutures are difficult to place and require well
trained and experienced surgeons.
Concerning robotic surgery, procedure is easier than
laparoscopy, thanks to easier sutures and access. The learning
curve is significantly shorter in robotic surgery especially
for complex procedures (10). Myomectomy through robotic
surgery has been reported to be effective and safe since 2004
(11). In the retrospective study of Advincula et al. (12) that
compared conventional laparotomy and robotic laparoscopy, the
robotic surgery needed longer operating time: 231.38 85.1 vs.
154.41 43.14min (p< 0.05) but with this technique blood loss
and length of hospital stay were significantly reduced; laparotomy
was associated with higher rates of morbidity.
The longer operating time associatedwith the robotic technique
is related to the time necessary to set up the robot and to myoma
extraction by morcellation.
The results of studies that evaluated robotic myomectomy
vs. conventional laparoscopic myomectomy showed reduced
blood loss and hospital stay, and conversion rates= 0 when
laparoscopy was robotically assisted (12–16). In 2008, Ascher-
Walsh et al. (17) have assessed 75 robotically assisted laparo-
scopic myomectomies vs. 50 conventional laparoscopic myomec-
tomies: lengthened operating time was reported with the robotic
technique (192 vs. 138min) but blood loss was reduced (226
vs. 459ml) and the duration of hospital stay was shorter (0.5
vs. 3.3 days). Even if short-term benefits of robotic assistance
appear to be modest in standard myomectomy, in some complex
cases and atypical locations (such as deep intramural fibroids,
broad ligaments, uterine isthmus, anterior and posterior loca-
tions), the advantages of robotically assisted surgery allow over-
coming laparoscopy limits (18, 19). In our study, the aver-
age blood loss was high: 384ml. It is probably due to one
case of important bleeding (1000ml) with laparoconversion and
some cases of big myomas (more than 10 cm). In these cases,
robotic surgery is probably limited and laparotomy should be
preferred.
Few studies reported on long-term side effects and benefit.
Lonnersfors et al. describe a 68% pregnancy rate with a mean
time to pregnancy (TTP) of 10months. The study reported on
31 patients operated for an interstitial fibroid that deformed the
uterine cavity. In 55% of cases, pregnancies were spontaneous
(20). In a retrospective study on 872womenoperated formyomec-
tomy, Pitter et al. reported 107 pregnancies after surgery. This
latter study reported that pregnancy chances and uterine rupture
rates (1%) were similar in the laparoscopic vs. robotic surgery
arms. Only 11% of women delivering by cesarean section had
adhesions, which is less than the rates commonly encountered
after surgery by laparoscopy. These numbers still need to be
interpreted cautiously, as it only included few patients. The pos-
sible advantage of robotic surgery is primarily resting on the
quality of sutures that might be similar to that of laparotomy,
easily realizing two or three planes of adequate quality. In terms
of long-term outcome, larger studies are needed to evaluate the
rates of pregnancy after myomectomy by robotically assisted
laparoscopy vs. laparotomy and the risk of secondary uterine
rupture.
The cost of robotic myomectomy remains higher than those
of conventional laparoscopy and laparotomy, with actual costs
depending on reimbursement systems. In the US, Behera et al.
(21) estimated the mean cost of robotically assisted myomectomy
to be $7299, that of conventional laparoscopy $6219, and that of
the abdominal route $4937.
Limits of robotic surgery still remain size and number of
myomas. In our study, we reported two conversions for large
myomas (13 and 15 cm).Myomas larger than 10 cmandmore than
4 myomas should beneficiated a laparotomy procedure.
Another limitation of laparoscopy or robotic-assisted
laparoscopy is the morcellation.
Minimally invasive gynecologic surgeons who perform laparo-
scopic intraperitoneal morcellation should be aware of the recent
US Food and Drug Administration (FDA) warnings and possibil-
ity of litigation due to reports of intraperitoneal dissemination of
cancerous cells. On November 24, 2014, the FDA issued a state-
ment warning against using laparoscopic power morcellators in
themajority of women undergoing hysterectomy ormyomectomy
for uterine fibroids (22).Morcellation should be performedwithin
a contained environment to minimize any potential tumor spread
in the event of an undiagnosed malignancy (23).
Conclusion
Robotic myomectomy appears to reduce morbidity rates, offers
better esthetic results, causes less adhesions, and features faster
recovery as compared to myomectomy performed by regular
laparoscopy. Compared with laparoscopy, robotic surgery allows
to remove larger and less accessiblemyomas. The quality of sutures
seems to equal that achieved by laparotomy, even if insufficient
data on uterine rupture are currently available. Moreover, the
possibilities of robotic surgery are bound to support the spread-
ing of minimally invasive surgery. However, the price of robotic
surgery still restrains its access. Ultimately, randomized clinical
trials (RCTs) are urgently needed to support with data the recent
tendencies observed in favor of robotic surgery.
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